Angela Lundy v. State of Indiana

26 N.E.3d 656, 2015 Ind. App. LEXIS 104, 2015 WL 728089
CourtIndiana Court of Appeals
DecidedFebruary 20, 2015
Docket49A02-1405-CR-307
StatusPublished
Cited by2 cases

This text of 26 N.E.3d 656 (Angela Lundy v. State of Indiana) is published on Counsel Stack Legal Research, covering Indiana Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Angela Lundy v. State of Indiana, 26 N.E.3d 656, 2015 Ind. App. LEXIS 104, 2015 WL 728089 (Ind. Ct. App. 2015).

Opinion

VAIDIK, Chief Judge.

Case Summary

[1] Angela Lundy was charged with Class D felony possession of a controlled substance. The existence of a valid prescription is a defense to this crime. Lundy served a subpoena on non-party Indiana Board of Pharmacy (“the Board”), requesting a copy of her INSPECT report. As part of the INSPECT program, the Board compiles controlled-substance information into an online database.

[2] The Board filed a motion to quash the subpoena, claiming that the information was confidential pursuant to statute. The trial court granted the Board’s motion because it found that Lundy had to make a threshold showing that she could not get her prescription records elsewhere before she was entitled to her INSPECT report from the Board. The trial court certified its ruling for interlocutory appeal.

[3] There is a three-part balancing test for discoverable information in a criminal proceeding, but the only consideration at issue here is particularity, which requires a showing that the information is not readily available elsewhere. The Board argues that because Lundy knew where she could “possibly” obtain her prescription records, they were readily available. *658 “Readily available,” however, does not equate to knowledge. That is, just because Lundy knew where she could “possibly” obtain her prescription records does not mean that they were “readily available” to her. In addition, the particularity requirement is not to be construed strictly against the defendant but should be administered so as to maximize pretrial discovery. Given that the Board does not challenge the other parts of the test, we conclude that the trial court abused its discretion in granting the Board’s motion to quash Lundy’s subpoena. We therefore reverse and remand this case to the trial court.

Facts and Procedural History

[4] According to the probable-cause affidavit, on August 8, 2013, Indianapolis Metropolitan Police Department officers found a prescription bottle for alprazolam (Xanax) in Lundy’s possession. The bottle contained one alprazolam pill but ten hy-drocodone pills. Lundy was arrested for possession of the hydrocodone pills.

[5] The State charged Lundy with Class D felony possession of a controlled substance for possessing hydrocodone—a Schedule II drug—without a valid prescription or order of a practitioner acting in the course of the practitioner’s professional practice. Ind.Code Ann. § 35-48-4-7 (West 2012); Appellant’s App. p. 12. The existence of a valid prescription for a controlled substance is a defense to the crime of possession. Williams v. State, 959 N.E.2d 360, 363 (Ind.Ct.App.2012). The defendant bears the burden of proving this defense by a preponderance of the evidence. Id.

[6] On December 3, 2013, Lundy served a request for production of documents by a non-party and a subpoena duces tecum on “INSPECT RX.” Appellant’s App. p. 35. Specifically, Lundy requested a “certified copy of any and all prescription records for Angela Lundy” and gave her date of birth and social-security number. Id. at 36. At the time of this request, Lundy “knew where she could possibly obtain records of her prescription.” 1 Id. at 60.

[7] INSPECT 2 is Indiana’s electronic prescription monitoring program, which is administered by the Indiana Board of Pharmacy. Williams, 959 N.E.2d at 363. It was designed to serve as a tool to address the problem of prescription-drug abuse and diversion in Indiana. Indiana Professional Licensing Agency, INSPECT Purpose & Goals, IN.gov, http://www.in. gov/pla/inspect/2338.htm (last visited Feb. 9, 2015). By compiling controlled-substance information into an online database, INSPECT performs two critical functions: (1) maintains a warehouse of patient information for health-care professionals and (2) provides an important investigative tool for law enforcement. Id. Specifically, the INSPECT program maintains a searcha-ble, online database compiled from information that is required by law to be transmitted by controlled-substance dispensers, including the controlled-substance recipient’s name, identification number, date of birth, and method of payment for the controlled substance dispensed; the date the controlled substance is dispensed; the quantity and number of days’ supply of the controlled substance; and the United States Drug Enforcement Agency registration number for both the prescriber and the dispenser. Ind.Code §§ 35-48-7- *659 8.1, -10.1. An INSPECT report then summarizes the controlled substances a patient has been prescribed, the practitioner who prescribed them, and the dispensing pharmacy where the patient obtained them. Indiana Professional Licensing Agency, About INSPECT, IN'.gov, http://www.in. gov/pla/inspect/2338.htm (last visited Feb. 9, 2015). ■ The information received is confidential and may be disclosed to only certain individuals. Ind.Code § 35-48-7-11.1(d). Notably, the patient is not listed as a person who is authorized to receive information from the INSPECT database. See Williams, 959 N.E.2d at 367 (“Conspicuously absent from the list of persons specifically authorized to receive information from the INSPECT database is the person for whom a controlled substance is prescribed and dispensed—in other words, the patient.”).

[8] The Board, represented by an attorney from the Office of the Indiana Attorney General, filed a motion to quash Lundy’s subpoena duces tecum on the grounds that the requested records were confidential pursuant to statute. Appellant’s App. p. 27-32. The trial court held two hearings on the Board’s motion to quash. At the first hearing in January 2014, the parties discussed this Court’s recent decision in Williams. The trial court ruled that Williams required Lundy to make a threshold showing that she could not get her prescription records elsewhere before she was entitled to her INSPECT report from the Board. Therefore, the court continued the hearing until March 2014 to give Lundy an opportunity to make this showing. Defense counsel said that she did not want Lundy to testify. Tr. p. 16, 19. In the meantime, the trial court urged the parties to resolve the matter on their own. Id. at 28.

[9] At the beginning of the hearing in March 2014, the Board attorney informed the trial court that he and defense counsel “were not able to come to an informal resolution” so “the Board would ask the Court [to] make a ruling on its Motion to Quash.” Id. at 34. Defense counsel did not present any evidence. The trial court granted the Board’s motion to quash and certified its ruling for interlocutory appeal. In June 2014 we accepted jurisdiction of this appeal.

Discussion and Decision

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
26 N.E.3d 656, 2015 Ind. App. LEXIS 104, 2015 WL 728089, Counsel Stack Legal Research, https://law.counselstack.com/opinion/angela-lundy-v-state-of-indiana-indctapp-2015.